Collaborative Care: Technology’s Evolving Role in Cardiometabolic Health is a 3-part feature series examining the evolution of technology in the management of patients with cardiometabolic diseases, such as cardiovascular disease and diabetes.
Since the dawn of medicine, the care of patients has only gone as far as the technology of the time has allowed it. From therapies, to monitoring, and even analysis of data, major advances in technology throughout history have opened the doors to a greater understanding and contributed to improvements in quality of life and clinical outcomes for patients.
Like a river creating a canyon, the process is often one that is grueling but the results can be far greater than most could have imagined. Not all endocrinologists could have predicted the incredible rise in continuous glucose monitors and insulin pumps, nor could many cardiologists have predicted hundreds of thousands of people wearing devices capable of conducting and submitting data from electrocardiograms on their wrists—yet, these advances have become integrated into our day-to-day lives.
With a greater emphasis, especially in the wake of COVID-19, implementation of and reimbursement for services delivered via telehealth have taken center stage, but many still lack answers to basic questions related to the topic. Co-hosted by Endocrinology Network and Practical Cardiology, “Collaborative Care: Technology’s Evolving Role in Cardiometabolic Health” is a feature series including a trio of submitted columns tackling these issues, each with a unique perspective.
In the first segment, hosted by Practical Cardiology, Brett Nowlan, MD, details the rise of wearables from his frame of reference as a practicing cardiologist. The second segment, which appears on Endocrinology Network, Melissa Young, MD, writes about how she has seen the evolution of diabetes technology transform the lives of patients. Lastly, Daniel Tashnek, JD, provides clinicians with information related to cost, coverage, and reimbursement for telehealth services and remote patient monitoring.
Trained in South Africa and experienced practicing in both Europe and the United States, Brett Nowlan, MD, has a perspective on cardiology that spans both continents and decades. With his unique point-of-view, Nowlan dives deeper into the journey of wearable technology from a cardiologist’s perspective.
An endocrinologist practicing in New Jersey, Melissa L. Young, MD, of Mid Atlantic Diabetes and Endocrinology, reflects on her personal experiences with treating diabetic patients over time as technology, such as glucose monitors and insulin pumps, have altered standards of practice.
With a background as a practicing healthcare attorney, Daniel Tashnek, JD, has spent his career looking to improve the care of patients through advocacy for telehealth use. The co-founder of a healthcare software company, Tashnek offers a wealth of knowledge related to regulatory compliance and reimbursement of telehealth services.